SCHEMBL14911192

SCHEMBL14911192

CC(C)C(CN(C(=O)O)C(C)(C)C)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.36
TRPV3 Q8NET8 2/20 0.32
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14911191 1.00 KHK (0.36) KHKTRPV3TRPA1
SCHEMBL14910363 0.90 KHK (0.37) KHK
SCHEMBL14910361 0.90 KHK (0.37) KHK
SCHEMBL14911504 0.86 KHK (0.34) KHK
SCHEMBL14909516 0.86 KHK (0.34) KHK
SCHEMBL14908685 0.86 KHK (0.34) KHK
SCHEMBL14908690 0.84 KHK (0.34) KHK
SCHEMBL14908691 0.84 KHK (0.34) KHK
SCHEMBL14911846 0.83 CYP2D6 (0.36) KHK
SCHEMBL14909075 0.83 KHK (0.34) KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK KHK 2008/4885TRPV3 1017/4885TRPA1 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.